Mesa Arch Sunrise

News & Articles

Author: Barrow Media Relations

Erroneous Genetic Sequence ID’d in Specific Cells of ALS, FTD Patients

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with mean survival of two to five years and six to eight years, respectively. ALS is...

Barrow Surgeon Treats Essential Tremor with Focused Ultrasound

After more than a decade of living with a neurological disorder that causes involuntary and rhythmic shaking, an Arizona man has been relieved of his symptoms thanks to...

Study: Common Gout Medication Reduces Risk of Alzheimer’s, Parkinson’s, ALS

Related Coverage A groundbreaking national study co-authored by a Barrow Neurological Institute neurologist and researcher has found a common gout medication reduced risk of Alzheimer’s disease, Parkinson’s disease,...

FDA Grants Approval of New Drug Therapy to Slow the Progression of ALS

Phoenix’s Barrow Neurological Institute Instrumental in Studies that Led to Today’s FDA Approval A leading amyotrophic lateral sclerosis (ALS) neurologist at Barrow Neurological Institute played an important role...

Top Seven of Seven Series – 2022

While Dr. Lawton takes hiatus a from operating this week to enjoy some spring break skiing, we will be counting down the top seven episodes of Seven Series...